The markets are volatile with a bearish bias, and the Nifty and Sensex are bearing the brunt. A closer look, however, reveals that, even in...

In the last few weeks, the range in which the nifty had been moving has become broader as the volatility has increased both due to internat...

As the market moves from clearly bullish mode to volatile mode with a bearish bias, there will be readjustment in valuation across markets....

In volatile markets, where there is a readjustment in valuation across midcap space, it is only a matter of time that the concept of relati...

While the correction has been going on in the market since the middle of July, it is only on days like Monday where everyone on the street ...

While they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...

As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...

As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...

As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of financial instit...

As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of financial instit...

In an already volatile market, bears are being helped by global events. However there are few large cap stocks which are finding favor with...

In otherwise volatile markets, bulls are once again making an attempt to come back. There are few large cap stocks which are finding favor ...

As the market witnesses volatile movement and bearish bias once again comes back to the street. There are few large cap stocks which are st...

As the market witnesses volatile movement and bearish bias once again comes back to the street. There are few large cap stocks which are st...

As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...

Companies have expanded the scope of their strategic partnership for cytokine reduction therapy, CytoSorb, to treat patients experiencing s...

Kiran Mazumdar Shaw said the partnership will enable the company to address the huge unmet need of sepsis management in India and emerging ...